Portrait of Jennifer Geremia

Jennifer Geremia,

MSPAS, PA-C

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women’s Hospital & Teaching Hospital of Harvard Medical School
Portrait of Jennifer Geremia

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women’s Hospital & Teaching Hospital of Harvard Medical School

Jennifer Geremia, MSPAS, PA-C, is a practicing physician associate (PA) in outpatient gastroenterology (GI) and advanced endoscopy at Brigham and Women’s Hospital in Boston at Teaching Hospital of Harvard Medical School. With GI experience for 14 years, including providing community and tertiary care across the spectrum of GI disease states, Jennifer is committed to patient care. She obtained a master’s degree in physician assistant studies from Massachusetts College of Pharmacy and Health Sciences. She is part of the clinical faculty at Massachusetts College of Pharmacy and Health Sciences PA Program, adjunct professor with GI experience at the University of New England PA program, and the Massachusetts General Hospital School of Health Professions PA Program. Also, she is a conference faculty presenter for the Gastroenterology and Hepatology Advanced Practice Providers National Organization and an advanced practice provider contributor to the American Society for Gastrointestinal Endoscopy.

Jennifer's Shared Resources

Direct-Acting Antivirals Allow HCV Treatment for Substance Users Without Abstinence

Substance use disorders affect roughly 25% of Americans aged 12 and older, with illicit drug use prevalent in 2022. The...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

WHO Prequalifies First HCV Self-Test to Expand Global Access and Elimination Efforts

The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test, OraQuick HCV self-test, manufactured by OraSure...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

New Strategies in HCV Treatment and Vaccine Development: Advances and Challenges

Hepatitis C virus (HCV) remains a significant global health challenge, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma. Direct-acting...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

APOE4’s Paradoxical Role: Increased COVID-19 Severity but Protection in HCV Liver Disease

Hepatitis C virus (HCV) and COVID-19 both affect the liver and cardiovascular systems, with the APOE4 allele playing a complex...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Update on Hepatitis C Care Paradigm for Healthcare Practitioners

The care paradigm for hepatitis C has recently shifted. This activity helps ensure healthcare practitioners, including hepatologists, gastroenterologists, primary care...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Risk Factors for Liver-Related Events Post-SVR in Patients With Hepatitis C

An observational, retrospective study examined the risk factors for liver-related events (LREs) after achieving sustained virological response (SVR) with direct-acting...
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Provided by an unrestricted grant from

Provided by an unrestricted grant from

Share